Clinical Trial: An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title:

Brief Summary: The purpose of this study is to investigate the superiority of KPS-0373 to placebo, and evaluate the safety of KPS-0373 in SCD patients.

Detailed Summary:
Sponsor: Kissei Pharmaceutical Co., Ltd.

Current Primary Outcome: SARA (Scale for the Assessment and Rating of Ataxia) [ Time Frame: 24 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome: SF-8(QOL) [ Time Frame: 24 weeks ]

Original Secondary Outcome: Same as current

Information By: Kissei Pharmaceutical Co., Ltd.

Dates:
Date Received: August 31, 2016
Date Started:
Date Completion:
Last Updated: November 11, 2016
Last Verified: November 2016